Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study

References

• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2352.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Federation; International Atherosclerosis Society; and International association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Essick EE, Sam F. Cardiac hypertrophy and fibrosis in the metabolic syndrome: A role for aldosterone and the mineralcorticoid receptor. Int J Hypertens. 2011;346985.
   PubMedGoogle Scholar
• Thethi T, Kamiyama M, Kobori H. The link between the renin–angiotensin–aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep.2012;14:160–169.
   PubMed Web of Science ®Google Scholar
• Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (The Strong Heart Study). Am J Cardiol. 2004;93: 40–44.
   PubMed Web of Science ®Google Scholar
• Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens. 2007;21:795–801.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens. 2004;22: 1991–1998.
   PubMed Web of Science ®Google Scholar
• Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Parodi A, et al. Metabolic syndrome is associated with early signs of organ damage in non-diabetic, hypertensive patients. J Intern Med. 2005;257:454–460.
   PubMed Web of Science ®Google Scholar
• Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G. et al.Influence of the metabolic syndrome on hypertension-related target organ damage. J Intern Med. 2005;257: 503–513.
   PubMed Web of Science ®Google Scholar
• Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome. The Bogalusa Heart Study. J Am Coll Cardiol. 2005;46:457–463.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, Mancia G. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima media thickness. J Hypertens. 2007;25:2463–2470.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A, Mancia G. Age and target organ damage in essential hypertension: Role of the metabolic syndrome. Am J Hypertens. 2007;20:296–303.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, et al. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension. 2006;47:881–886.
   PubMed Web of Science ®Google Scholar
• Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early atherosclerosis in women than in men. Stroke. 2005;36: 1212–1217.
   PubMed Web of Science ®Google Scholar
• Aijaz B, Ammar KA, Lopez-Jimenez S, Redfield MM, Jacobsen SJ, Redeheffer RJ. Abnormal cardiac structure and function in the metabolic syndrome: A population-based study. Mayo Clin Proc. 2008;83:1350–1357.
   PubMed Web of Science ®Google Scholar
• Halldin M, Fahlstadius P, De Faire U, Vikstrom M, Hellenius ML. The metabolic syndrome and left ventricular hypertrophy, the influence of gender and physical activity. Blood Press. 2012;21:153–160.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reickek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
   PubMed Web of Science ®Google Scholar
• Pignoli P, Tremoli E, Poli A, Paoletti R. Intimal plus media thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1408.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I, et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected population: Impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press. 2001;10:142–149.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Facchetti R, Sala C, Bombelli M, Negri F, Carugo S, et al. Normal values of left ventricular mass: Echocardiographic findings from the Pamela population. J Hypertens. 2012;30:997–1003.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949–961.
   PubMed Web of Science ®Google Scholar
• 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007:25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage and prognosis. Hypertension. 2007;49:40–47.
   PubMed Web of Science ®Google Scholar
• Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448–454.
   PubMed Web of Science ®Google Scholar
• de Simone G. State of the art in the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2005;15:239–241.
   PubMed Web of Science ®Google Scholar
• Guerra F, Mancinelli L, Angelini L, Fortunati M, Rappelli S, Dessì-Fulgheri P, Sarzani R. The association between left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in overweight or obese hypertensives. PLoS ONE. 2011;6(1):e16630.
   Google Scholar